These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34548392)

  • 1. Ontogeny of Small Intestinal Drug Transporters and Metabolizing Enzymes Based on Targeted Quantitative Proteomics.
    Kiss M; Mbasu R; Nicolaï J; Barnouin K; Kotian A; Mooij MG; Kist N; Wijnen RMH; Ungell AL; Cutler P; Russel FGM; de Wildt SN
    Drug Metab Dispos; 2021 Dec; 49(12):1038-1046. PubMed ID: 34548392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Atlas of Cytochrome P450, UDP-Glucuronosyltransferase, and Transporter Proteins in Jejunum of Morbidly Obese Subjects.
    Miyauchi E; Tachikawa M; Declèves X; Uchida Y; Bouillot JL; Poitou C; Oppert JM; Mouly S; Bergmann JF; Terasaki T; Scherrmann JM; Lloret-Linares C
    Mol Pharm; 2016 Aug; 13(8):2631-40. PubMed ID: 27347605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Tissue Abundance of Membrane-Bound Drug Metabolizing Enzymes and Transporter Proteins by Global Proteomics.
    Singh DK; Ahire D; Davydov DR; Prasad B
    Drug Metab Dispos; 2024 Oct; 52(11):1152-1160. PubMed ID: 38641346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein Abundance of Clinically Relevant Drug Transporters in the Human Liver and Intestine: A Comparative Analysis in Paired Tissue Specimens.
    Drozdzik M; Busch D; Lapczuk J; Müller J; Ostrowski M; Kurzawski M; Oswald S
    Clin Pharmacol Ther; 2019 May; 105(5):1204-1212. PubMed ID: 30447067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Hepatic and Intestinal Efflux Transport of Statins.
    Deng F; Tuomi SK; Neuvonen M; Hirvensalo P; Kulju S; Wenzel C; Oswald S; Filppula AM; Niemi M
    Drug Metab Dispos; 2021 Sep; 49(9):750-759. PubMed ID: 34162690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Characterization of Clinically Relevant Drug-Metabolizing Enzymes and Transporters in Rat Liver and Intestinal Segments for Applications in PBPK Modeling.
    Sharma S; Singh DK; Mettu VS; Yue G; Ahire D; Basit A; Heyward S; Prasad B
    Mol Pharm; 2023 Mar; 20(3):1737-1749. PubMed ID: 36791335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional Expression Levels of Drug Transporters and Metabolizing Enzymes along the Pig and Human Intestinal Tract and Comparison with Caco-2 Cells.
    Vaessen SF; van Lipzig MM; Pieters RH; Krul CA; Wortelboer HM; van de Steeg E
    Drug Metab Dispos; 2017 Apr; 45(4):353-360. PubMed ID: 28153842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Regional-Specific Relative and Absolute Expression of Gut Transporters in Adult Caucasians: A Meta-Analysis.
    Harwood MD; Zhang M; Pathak SM; Neuhoff S
    Drug Metab Dispos; 2019 Aug; 47(8):854-864. PubMed ID: 31076413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Intestinal PEPT1 Transporter Expression and Localization in Preterm and Term Infants.
    Mooij MG; de Koning BE; Lindenbergh-Kortleve DJ; Simons-Oosterhuis Y; van Groen BD; Tibboel D; Samsom JN; de Wildt SN
    Drug Metab Dispos; 2016 Jul; 44(7):1014-9. PubMed ID: 27079248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Proteomics of Clinically Relevant Drug-Metabolizing Enzymes and Drug Transporters and Their Intercorrelations in the Human Small Intestine.
    Couto N; Al-Majdoub ZM; Gibson S; Davies PJ; Achour B; Harwood MD; Carlson G; Barber J; Rostami-Hodjegan A; Warhurst G
    Drug Metab Dispos; 2020 Apr; 48(4):245-254. PubMed ID: 31959703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of Mucosal Membrane Transporters and Drug-Metabolizing Enzymes in Ulcerative Colitis.
    Erdmann P; Bruckmueller H; Martin P; Busch D; Haenisch S; Müller J; Wiechowska-Kozlowska A; Partecke LI; Heidecke CD; Cascorbi I; Drozdzik M; Oswald S
    J Pharm Sci; 2019 Feb; 108(2):1035-1046. PubMed ID: 30267783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted quantitative proteomic analysis of drug metabolizing enzymes and transporters by nano LC-MS/MS in the sandwich cultured human hepatocyte model.
    Khatri R; Fallon JK; Rementer RJB; Kulick NT; Lee CR; Smith PC
    J Pharmacol Toxicol Methods; 2019; 98():106590. PubMed ID: 31158457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interactions of lenalidomide with human uptake and efflux transporters and UDP-glucuronosyltransferase 1A1: lack of potential for drug-drug interactions.
    Tong Z; Yerramilli U; Surapaneni S; Kumar G
    Cancer Chemother Pharmacol; 2014 Apr; 73(4):869-74. PubMed ID: 24627218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor.
    Reese MJ; Savina PM; Generaux GT; Tracey H; Humphreys JE; Kanaoka E; Webster LO; Harmon KA; Clarke JD; Polli JW
    Drug Metab Dispos; 2013 Feb; 41(2):353-61. PubMed ID: 23132334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of intestinal drug transporter proteins and metabolic enzymes in neonatal and pediatric patients.
    de Waal T; Handin N; Brouwers J; Miserez M; Hoffman I; Rayyan M; Artursson P; Augustijns P
    Int J Pharm; 2024 Apr; 654():123962. PubMed ID: 38432450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of an LC-MS/MS method for the simultaneous quantification of human intestinal transporter proteins absolute abundance using a QconCAT technique.
    Harwood MD; Achour B; Russell MR; Carlson GL; Warhurst G; Rostami-Hodjegan A
    J Pharm Biomed Anal; 2015 Jun; 110():27-33. PubMed ID: 25796981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Hepatic UDP-Glucuronosyltransferase Enzyme Abundance-Activity Correlations and Population Variability Using a Proteomics Approach and Comparison with Cytochrome P450 Enzymes.
    Takahashi RH; Forrest WF; Smith AD; Badee J; Qiu N; Schmidt S; Collier AC; Parrott N; Fowler S
    Drug Metab Dispos; 2021 Sep; 49(9):760-769. PubMed ID: 34187837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related changes in mRNA levels of hepatic transporters, cytochrome P450 and UDP-glucuronosyltransferase in female rats.
    Kawase A; Ito A; Yamada A; Iwaki M
    Eur J Drug Metab Pharmacokinet; 2015 Jun; 40(2):239-44. PubMed ID: 24899460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of variations in the amounts of P-glycoprotein (ABCB1), BCRP (ABCG2) and CYP3A4 along the human small intestine on PBPK models for predicting intestinal first pass.
    Bruyère A; Declèves X; Bouzom F; Ball K; Marques C; Treton X; Pocard M; Valleur P; Bouhnik Y; Panis Y; Scherrmann JM; Mouly S
    Mol Pharm; 2010 Oct; 7(5):1596-607. PubMed ID: 20604570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ontogeny of human hepatic and intestinal transporter gene expression during childhood: age matters.
    Mooij MG; Schwarz UI; de Koning BA; Leeder JS; Gaedigk R; Samsom JN; Spaans E; van Goudoever JB; Tibboel D; Kim RB; de Wildt SN
    Drug Metab Dispos; 2014 Aug; 42(8):1268-74. PubMed ID: 24829289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.